Increased expression of interleukin-8 is associated with poor clinical outcome in ovarian cancer, and blocking it might offer a new therapeutic approach. Medscape Medical News
Consolidation treatment with radioactive yttrium-90 ibritumomab tiuxetan is feasible, well tolerated, and effective in untreated patients with follicular non-Hodgkin lymphoma. Medscape Medical News